These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 30107214)
1. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis. Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214 [TBL] [Abstract][Full Text] [Related]
2. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741 [TBL] [Abstract][Full Text] [Related]
3. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis. Huang Y; Guo J; Gui S Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858 [TBL] [Abstract][Full Text] [Related]
4. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation. Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161 [TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis. Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy. Xiong M; Li Y; He H; Hao S; Fang P; Xu M; Chen Y; Chen Y; Yu S; Hu H Eur J Pharm Biopharm; 2023 Aug; 189():152-164. PubMed ID: 37336365 [TBL] [Abstract][Full Text] [Related]
7. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery. He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844 [TBL] [Abstract][Full Text] [Related]
8. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis. Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114 [TBL] [Abstract][Full Text] [Related]
9. Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis. Zu M; Song H; Zhang J; Chen Q; Deng S; Canup BSB; Yuan Y; Xiao B Colloids Surf B Biointerfaces; 2020 Mar; 187():110747. PubMed ID: 31924469 [TBL] [Abstract][Full Text] [Related]
10. 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice. Tang H; Xiang D; Wang F; Mao J; Tan X; Wang Y Mol Med Rep; 2017 Mar; 15(3):1117-1122. PubMed ID: 28138699 [TBL] [Abstract][Full Text] [Related]
11. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics. Zhou X; Liu Y; Wang X; Li X; Xiao B Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717 [TBL] [Abstract][Full Text] [Related]
12. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles. Cheng W; Tang C; Yin C J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829 [TBL] [Abstract][Full Text] [Related]
13. Oral bomb effect nanotherapeutics alleviate ulcerative colitis through coordinated anti-inflammatory and pro-resolving strategies. Yang M; Zhu Y; Wei X; Feng J; He Y; Jiang J; Zhou Q; Zhang M; Zhang G; Ma W Biomater Sci; 2024 Oct; 12(20):5386-5403. PubMed ID: 39264298 [No Abstract] [Full Text] [Related]
14. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery. Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992 [TBL] [Abstract][Full Text] [Related]
15. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice. Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126 [TBL] [Abstract][Full Text] [Related]
17. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages. Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990 [TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis. Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486 [TBL] [Abstract][Full Text] [Related]
19. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306 [TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis. Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]